Anzeige
Erschienen in:
01.04.2024 | News item
Non-serious case reports
Erschienen in: Reactions Weekly | Ausgabe 1/2024
Einloggen, um Zugang zu erhaltenExcerpt
The table below provides a list of the drugs associated with non-serious adverse events identified in the scientific literature over the last week.|
Non-serious case reports
|
||
|---|---|---|
|
Drug name(s)
|
Adverse event(s)
|
No. of cases
|
|
Amiodarone
|
Thyroid dysfunction
|
1
|
|
Amivantamab
|
Gastrointestinal ulcer, Genital ulcer, Mouth disorders, Paronychia, Skin disorders, Xerostomia
|
1
|
|
Atezolizumab
|
Hypophysitis
|
1
|
|
Benralizumab, Dupilumab
|
Asthma, Eczema, Vesiculobullous skin diseases
|
1
|
|
Brimonidine, Dorzolamide, Netarsudil
|
Signs symptoms and ill defined conditions
|
1
|
|
Cabozantinib
|
Signs symptoms and ill defined conditions
|
1
|
|
Cariprazine
|
Psychomotor agitation, Weight loss
|
1
|
|
Cetuximab
|
Hypersensitivity
|
2
|
|
Chlormethine
|
Haemangioma
|
1
|
|
Cisplatin, Gimeracil/oteracil/tegafur
|
Fatigue
|
1
|
|
Colestyramine, Diltiazem, Potassium iodide, Propranolol, Thiamazole
|
Arrhythmias, Graves’ disease, Heart failure, Lack of efficacy in life threatening diseases
|
1
|
|
COVID 19 vaccine
|
Lymphadenopathy
|
1
|
|
Dabigatran etexilate
|
Haemorrhage
|
1
|
|
Elexacaftor/Ivacaftor/tezacaftor
|
Depression
|
1
|
|
Emicizumab
|
Abnormal laboratory parameters, False test results
|
1
|
|
Etoposide, Ifosfamide, Prednisone
|
Exanthema, Pustular psoriasis
|
1
|
|
Fentanyl, Oxycodone, Oxycodone/paracetamol, Tramadol
|
Anxiety, Insomnia
|
1
|
|
Ferric carboxymaltose
|
Hypophosphataemia
|
1
|
|
Gemfibrozil, Omega 3 acid ethyl esters
|
Pregnancy
|
1
|
|
Glibenclamide
|
1
|
|
|
Immune globulin
|
Desquamation
|
1
|
|
Inclisiran
|
Dizziness, Injection site reactions
|
1
|
|
Insulin
|
Hypoglycaemia
|
1
|
|
Ketotifen
|
Constipation
|
1
|
|
Labetalol, Metformin
|
Pregnancy
|
1
|
|
Liraglutide
|
Abnormal laboratory parameters
|
1
|
|
Melatonin
|
Dermatitis
|
1
|
|
Melphalan
|
Hypersensitivity
|
1
|
|
Methylprednisolone
|
Infections, Injection site reactions
|
1
|
|
Multimineral/multivitamin
|
Thyroid dysfunction
|
1
|
|
Naltrexone
|
Pain
|
1
|
|
Nifedipine
|
Oedema, Tongue disorders
|
1
|
|
Olanzapine
|
Oedema, Tongue disorders
|
1
|
|
Patisiran
|
Infusion related reaction
|
1
|
|
Pembrolizumab
|
Inflammation
|
1
|
|
Perflutren
|
Back pain, Exanthema
|
2
|
|
Prednisolone
|
Malakoplakia
|
1
|
|
Rituximab
|
Infusion related reaction
|
1
|
|
Semaglutide
|
Gastrointestinal disorders
|
3
|
|
Sirolimus
|
Oral ulcer
|
1
|
|
Sorafenib
|
Diarrhoea, Exanthema
|
1
|
|
Teprotumumab
|
Hyperglycaemia, Spasm
|
2
|
|
Valproate
|
Psychiatric disorders
|
1
|